2PHARMA
ActiveSummary
2PHARMA has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €779,467 and a net result of €120,628. Equity is growing by about 15% per year across the filed financial years. Its solvency ranks better than 76% of 6,035 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
History
Acts, filings and financial milestones
29-04
Gazette deed
Reappointments: MD CONSULT, AQUITANIA and SDV CONSULTResignations: MD CONSULT, AQUITANIA and SDV CONSULT · Appointments: MD CONSULT (director) and AQUITANIA (director) · Amendment of the articles16 facts ▸
- General meeting, 30-03-2026
- Amendment of the articles (2 times)
- Capital, €375,000
- Registered office clause, “9051 Gent, Kortrijksesteenweg 1091 B” (deed in Dutch)
- Director reappointment, MD CONSULT (director)
- Director reappointment, AQUITANIA (director)
- Director reappointment, SDV CONSULT (director)
- Director reappointment, MD CONSULT (managing director)
- Director resignation, MD CONSULT (director)
- Director resignation, AQUITANIA (director)
- Director resignation, SDV CONSULT (director)
- Board composition, “MONISTISCH BESTUUR, 20 tot en met 28” (deed in Dutch)
- +4 further facts in this act
About the unread acts
Of the 11 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 10 have not been read yet: what they contain is neither established nor disproved here.